Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis

Experimental Biology and Medicine

Volumn 227, Issue 10, 2002, Pages 886-893

  Bowen, Phyllis ^a   Chen, Longwen ^a   Stacewicz Sapuntzakis, Maria ^a   Duncan, Claudine ^a   Sharifi, Roohollah ^a   Ghosh, Luna ^a   Kim, Hyung Sook ^a   Christov Tzelkov, Konstantin ^a   Van Breemen, Richard ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

8 Hydroxydeoxyguanoisine; Aptosis; DNA damage; Lycopene isomers; Prostate cancer; Prostate specific antigen; Tomatoes

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE DERIVATIVE; DNA; LYCOPENE; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; CANCER CELL; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DNA DAMAGE; DOSE RESPONSE; FOOD INTAKE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; LEUKOCYTE; MALE; PASTA; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; TOMATO; TUMOR CELL;

LYCOPERSICON ESCULENTUM;

EID: 0036845479     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222701008     Document Type: Conference Paper

References (47)

1. Giovannucci E, Ascherio A, Rimm EB, Stampher MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in the relation to risk of prostate cancer. J Natl Cancer Inst 87:1767-1776, 1995.
2. Gann PH, Ma J, Giovannucci E, Willet W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. J Cancer Res 59:1225-1230, 1999.
3. The α-Tocopherol B-CCPSG. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035, 1994.
4. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996.
5. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532-538, 1989.
6. Woodall AA, Britton G, Jackson MJ. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. Biochim Biophys Acta 1336:575-586, 1997.
7. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 31:199-203, 1998.
8. Riso P, Pinder A, Santangelo A, Porrini M. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr 69:712-718, 1999.
9. Porrini M, Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr 130:189-192, 2000.
10. Rehman A, Bourne LC, Halliwell B, Rice-Evans CA. Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 262:828-831, 1999.
11. Cerutti PA. Prooxidant states and tumor promotion. Science 227:375-380, 1985.
12. Ames BN, Shigenaga MK, Park EM. DNA damage by endogenous oxidants as a cause of aging and cancer. In: Kelvin JA, Ed. Oxidative Damage and Repair: Chemical, Biological and Medical Aspects. New York: Pergamon Press, pp181, 1990.
13. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 74:297-312, 1996.
14. Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr 72:1082-1087, 2000.
15. De Marzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyyperplasia. Urology 53(Suppl 3A):29-40, 1999.
16. Toyokuni S, Tomoyuki T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76:365-374, 1997.
17. Stacewicz-Sapuntzakis M, Bowen PE, Kikendall JW, Burgess M. Simultaneous determination of serum retinol and various carotenoids: their distribution in middle-aged men and women. J Micronut Analysis 3:27-45, 1987.
18. Philips RW, Kikendall JW, Luk GD, Willis SM, Murphy JR, Maydonovitch C, Bowen PE, Stacewicz-Sapuntzakis M, Wong RKH. β-Carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Res 53:3723-3725, 1993.
19. Chen L, Bowen PE, Berzy D, Sapuntzakis M, Riley R. Diet modification affects DNA oxidative damage in health humans. Free Radic Biol Med 16:111-115, 1994.
20. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW. Cis-trans lycopene isomers, carotenoids and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5:823-833, 1996.
21. Porrini M, Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr 130:189-192, 2000.
22. Lavelli V, Peri C, Rissolo A. Antioxidant activity of tomato products as studied by model reactions using xanthine oxidase, myeloperoxidase, and copper-induced lipid peroxidation. J Agric Food Chem 48:1442-1448, 2000.
23. Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with α-tocopherol inhibits at physiological concentrations the proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 250:582-285, 1998.
24. Keukens EAJ, de Vrije T, Jansen LAM, de Boer H, Janssen M, de Kroon APM, Jongen WMF, de Kruijff B. Glycoalkaloids selectively permeabilize cholesterol containing biomembranes. Biochem Biophys Acta 1279:243-250, 1996.
25. Friedman M, Fitch TE, Yokayama WE. Lowering of plasma LDL cholesterol in hamsters by the tomato glycoalkloid tomatine. Food Chem Toxicol 38:549-553, 2000.
26. Leonardi C, Ambrosino P, Esposito F, Foglioano V. Antioxidant activity and carotenoid and tomatine contents in different typologies of fresh consumption tomatoes. J Agric Food Chem 48:4723-4727, 2000.
27. Hovenian MS, Deming CL. The heterologous growth of cancer of the human prostate. Surg Gynecol Obstet 86:29, 1948.
28. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5:823-833, 1996.
29. Schierle J, Bretzel W, Buhler N, Faccin D, Hess K, Steiner K, Schuep W. Content and isomeric ratio of lycopene in food and human blood plasma. Food Chem 59:459-465, 1997.
30. Muller H, Bub A, Watzl B, Rechkemmer G. Plasma concentrations of carotenoids in healthy volunteers after intervention with carotenoidrich foods. Eur J Nutr 38:35-44, 1999.
31. Holloway DE, Yang M, Paganga G, Rice-Evans CA, Bramely PM. Isomerization of dietary lycopene during assimilation and transport in plasma. Free Radic Res 32:93-102, 2000.
32. Boileau AC, Merchen NR, Wasson K, Atkinson CA, Erdman JW. Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr 129:1176-1186, 1999.
33. Tan B, Chu FL. Effects of palm carotenoids in rat hepatic cytochrome P450-mediated benzo(a)pyrene metabolism. Am J Clin Nutr 53:1071S-1075S, 1991.
34. Palozza P, Calviello G, Serini S, Maggiano N, Lanza P, Ranelletti FO, Bartoli GM. β-Carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radic Biol Med 30:1000-1007, 2001.
35. Palozza P. Prooxidant actions of carotenoids in biological systems. Nutr Rev 56:257-265, 1998.
36. Yeh S-L, Hu M-L. Antioxidant and pro-oxidant effects of lycopene in comparison with β-carotene on oxidant-induced damage of Hs68 cells. J Nutr Biochem 11:548-554, 2000.
37. Schwartz JL. The dual roles of nutrients as antioxidants and prooxidants: Their effect on tumor cell growth. J Nutr 126:1221S-1227S, 1996.
38. Xu X, Wang Y, Constantinou A, Stacewicz-Sapuntzakis M, Bowen P, van Breemen R. Solubilization and stabilization of carotenoids using micelles: Delivery of lycopene in cell culture. Lipids 34:1031-1036, 1999.
39. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leiononen J. Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsen before diagnosis of prostate cancer. Lancet 344:1594-1598, 1994.
40. Abbas F. Scardino PT. The natural history of clinical prostate carcinoma. Cancer 80:827-833, 1997.
41. Dew T, Coker C, Saadeh F, Mulvin D, Coptcoat MJ, Sherwood PA. Influence of investigative and operative procedures on serum prostate-specific antigen concentration. Ann Clin Biochem 36:340-346, 1999.
42. Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J Urol 157:195-198, 1997.
43. Levy J, Bosin E, Feldman B, Giat Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 24:257-266, 1995.
44. Countryman C, Bankson D, Collins S, Mar B. Lycopene inhibits the growth of the HL-60 promyelocytic leukemia cell line. Clin Chem 37:1056, 1991.
45. Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z, Cohen LA. Effects of a lycopene-rich diet on spontaneous benzo(a)pyreneinduced mutogenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett 10(164):1-6, 2001.
46. Matlaga BR, Hall CM, Stindt D, Torti FM. Response of hormone refractory prostate cancer to lycopene. J Urol 166:613, 2001.
47. Marks LS, Partin AW, Epstein JL, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, Dekernion JB. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 163:1451-1456, 2000.